PMC

Inhibition of ADCC activity by A32 Fab fragment. The A1953_CEM.NKR_CCR5 cell line was used as target cells, and PBMC from a healthy HIV-1-seronegative donor were used as a source of effector cells. The effector-to-target cell ratio was 30:1 in all experiments. The results are reported as percent GzB activity after background was subtracted. The values above the bars represent the percentage of inhibition when A32 Fab fragment, 17b Fab fragment, 7B2 Fab fragment, and palivizumab were used in the preincubation. (A) The target cells were preincubated with medium only (no pretreatment), with 10 μg/ml of the A32 Fab fragment, or with 10 μg/ml of palivizumab. The results represent the average of results from triplicate experiments. After being washed, the cells were incubated with 10 and 1 μg/ml of MAbs A32 and 2G12. (B) The plasma collected from 14 HIV-1-infected donors was added to A1953_CEM.NKR_CCR5 target cells preincubated as previously described with medium only (no pretreatment), A32 Fab fragment, 17b Fab fragment, 7B2, or palivizumab. The MAbs A32 and 17b were used as positive controls.

Changes in structural features of axons and density alter the relationship of ACC, OFC, and LPFC in autism. Interareal differences were assessed by subtraction of corresponding normalized values for each pair of areas. A, Differences between A32 (ACC) and A11 (OFC); positive numbers indicate higher values for A32 and negative numbers indicate higher values for A11. B, Differences between A46 (LPFC) and A11; positive numbers indicate higher values for A46 and negative numbers indicate higher values for A11. C, Differences between A32 and A46; positive numbers indicate higher values for A32 and negative numbers indicate higher values for A46. Blue dotted line and magenta-shaded area indicate mean and range for the control cases. Orange dotted line and yellow-shaded area show mean and range for autistic cases. Asterisks indicate significant differences between control and autistic cases (p<0.05).

Neuronal density and cortical thickness in ACC (A32) were not affected in the autistic cases. A, B, Photomontages of adjoining high magnification images of Nissl stained coronal sections, from the pial surface to the white matter of ACC, in a control (A) and an autistic (B) case. Dotted lines indicate borders (from top to bottom) between layers I, II/III, V/VI, and the white matter. A32 does not have well-delineated layer IV, comparable to the same area in the rhesus monkey (Barbas and Pandya, 1989). C, Estimated overall neuronal density ± SEM in ACC (A32) based on stereologic analysis. D, Plot of the laminar neuronal density ± SEM in A32. E, Mean cortical grey matter thickness ± SEM in sulcal, straight, and gyral, parts of A32 and overall average thickness.

CH08 mAb binding to gp140_Con.S after capture by mAb T8 (HIV gp120-specific mAb), soluble CD4 (sCD4), or mAb A32 (CD4 binding site mAb) was measured by SPR. A. gp140_Con.S bound to anchored T8, sCD4 and A32, data are shown in response units (RU). B. CH08 was flowed over the captured Env showing that it bound to Env captured by A32 and sCD4, but not Env captured by mAb T8. Peak CH08 binding as a fraction of bound Env is shown.